Dermatology, MOHS-Micrographic Surgery · Little Rock, AR
NPI
1922065044
Since 2006
Specialty
Dermatology, MOHS-Micrographic Surgery
Code 207ND0101X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
9601 Baptist Health Dr Ste 860
Little Rock, AR, 72205
Phone (501) 975-7455
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.0M
11,871 services
Medicare patients, 2024
870
Average age 78
Drug cost, 2024
$399K
271 prescriptions
Company payments, 2025
$39K
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Scott M Dinehart was code J7345 (aminolevulinic acid hcl for topical administration, 10% gel, 10 mg), 4,000 times for 15 patients. In total Scott M Dinehart billed 11,871 services in 109 codes, and Medicare paid $1.0M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-05-06.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J7345 Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 4,000 | 15 | $1.27 | $5,094 |
| 88331 Surgical Pathology Examination | Office | 1,646 | 593 | $69.54 | $114K |
| 88305 Surgical Pathology Examination | Office | 1,151 | 337 | $48.06 | $55K |
| 17003 Destruction Skin Lesion | Office | 1,017 | 143 | $4.43 | $4,509 |
| 17311 Mohs Surgery | Office | 450 | 320 | $420.37 | $189K |
| 99213 Office E&M - Established | Office | 341 | 213 | $54.25 | $19K |
| 11102 Skin Biopsy | Office | 306 | 204 | $44.28 | $14K |
| 17000 Destruction Skin Lesion | Office | 215 | 160 | $29.44 | $6,330 |
| 11103 Skin Biopsy | Office | 176 | 84 | $34.15 | $6,010 |
| 88302 Surgical Pathology Examination | Office | 168 | 73 | $22.50 | $3,781 |
| 88332 Surgical Pathology Examination | Office | 121 | 86 | $38.14 | $4,615 |
| 17312 Mohs Surgery | Office | 120 | 85 | $283.10 | $34K |
| 99212 Office E&M - Established | Office | 103 | 82 | $35.48 | $3,655 |
| 11602 Skin Lesion Excision | Office | 102 | 85 | $100.10 | $10K |
| 17313 Mohs Surgery | Office | 93 | 63 | $372.33 | $35K |
By year: 2022 $1.4M for 27,715 services; 2023 $1.3M for 19,644 services; 2024 $1.0M for 11,871 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88331 Surgical Pathology Examination | 1,646 | 593 | $69.54 | $114K |
| 88305 Surgical Pathology Examination | 1,151 | 337 | $48.06 | $55K |
| 88302 Surgical Pathology Examination | 168 | 73 | $22.50 | $3,781 |
| 88332 Surgical Pathology Examination | 121 | 86 | $38.14 | $4,615 |
Medicare prescription drug claims, 2024
In 2024, the drug Scott M Dinehart prescribed most often to Medicare patients was Doxycycline Hyclate, with 71 prescriptions and refills. In total Scott M Dinehart wrote 271 Medicare prescriptions that cost $399K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Doxycycline Hyclate Generic | 71 | 71 | 62 | $645 |
| Imiquimod Generic | 32 | 33 | 24 | $839 |
| Erivedge Vismodegib | 27 | 27 | Under 11 | $363K |
| Triamcinolone Acetonide Generic | 26 | 26 | 18 | $286 |
| Mupirocin Generic | 25 | 25 | 20 | $209 |
| Ketoconazole Generic | 17 | 17 | 12 | $285 |
| Acitretin Generic | 14 | 14 | Under 11 | $2,422 |
Brand drugs: 37 claims; generic drugs: 234 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Scott M Dinehart $39K ($36K in general payments such as food, travel and fees and $2,986 for research) from 19 companies. The largest payer was Sun Pharmaceutical Industries Inc. with $34K.
| Company | Payments | Amount |
|---|---|---|
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 29 | $34K |
| Regeneron Pharmaceuticals, Inc. REGN | 8 | $2,121 |
| Novartis Pharmaceuticals Corporation NVS | 10 | $2,010 |
| Lilly USA, LLC LLY | 3 | $134 |
| Janssen Biotech, Inc. JNJ | 1 | $111 |
| Pfizer Inc. PFE | 2 | $98.12 |
| LEO Pharma Inc. | 3 | $59.6 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $46.34 |
| Genzyme Corporation SNY | 1 | $25.68 |
| Amgen Inc. AMGN | 1 | $22.64 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.